Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (Q34532636)

2 August 2017

1 reference

title

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (English)

1 reference

2 August 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

Pui CH

1

1 reference

2 August 2017

Chessells JM

2

1 reference

2 August 2017

Camitta B

3

1 reference

2 August 2017

Baruchel A

4

1 reference

2 August 2017

Biondi A

5

1 reference

2 August 2017

Boyett JM

6

1 reference

2 August 2017

Carroll A

7

1 reference

2 August 2017

Eden OB

8

1 reference

2 August 2017

Evans WE

9

1 reference

2 August 2017

Gadner H

10

1 reference

2 August 2017

Harbott J

11

1 reference

2 August 2017

Harms DO

12

1 reference

2 August 2017

Harrison CJ

13

1 reference

2 August 2017

Harrison PL

14

1 reference

2 August 2017

Heerema N

15

1 reference

2 August 2017

Janka-Schaub G

16

1 reference

2 August 2017

Kamps W

17

1 reference

2 August 2017

Masera G

18

1 reference

2 August 2017

Pullen J

19

1 reference

2 August 2017

Raimondi SC

20

1 reference

2 August 2017

Richards S

21

1 reference

2 August 2017

Riehm H

22

1 reference

2 August 2017

Sallan S

23

1 reference

2 August 2017

Sather H

24

1 reference

2 August 2017

Shuster J

25

1 reference

2 August 2017

Silverman LB

26

1 reference

2 August 2017

Valsecchi MG

27

1 reference

2 August 2017

Vilmer E

28

1 reference

2 August 2017

Zhou Y

29

1 reference

2 August 2017

Gaynon PS

30

1 reference

2 August 2017

Schrappe M

31

1 reference

2 August 2017

1 April 2003

1 reference

2 August 2017

1 reference

2 August 2017

17

1 reference

2 August 2017

4

1 reference

2 August 2017

700-706

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402883

2 August 2017

0 references

cites work

Acute leukemias with the t(4;11)(q21;q23)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Analysis of time to death after transplantation when transplants are only given to patients in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Childhood acute lymphoblastic leukaemia--current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402883

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402883

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference